SearcharxivSearch

arXiv subjects

Laura B. Balzer

Publications and source records attributed to Laura B. Balzer.

At least 19 recordsLinked to original sources

Towards Best Practices for Covariate Adjustment in Regulatory Trials: From Fixed to Data-Adaptive Approaches

While randomization justifies the use of unadjusted effect estimators in randomized trials, there is growing interest in covariate adjustment to improve precision. Adjusting for baseline variables that are prognostic of the outcome can reduce estimator variance, resulting in narrower confidence intervals and increased statistical power. Recent guidance by the U.S. Food and Drug Administration supports fixed adjustment for prognostic covariates using parametric regression models. However, this guidance does not address more flexible approaches using data-adaptive or machine learning methods. We offer our perspectives on covariate adjustment to improve analytic precision. We focus on estimating the average effect for the target population in trials with minimal outcome missingness. We provide a non-technical overview of effect estimators that are unadjusted and effect estimators using fixed versus data-adaptive adjustment. We offer practical suggestions for conducting adjusted analyses that are data-adaptive, fully pre-specified, transparently and reproducibly implemented, robust to model misspecification, and guaranteed to improve precision relative to unadjusted analyses --- all while preserving statistical validity and the causal effect of interest. We hope that sharing our perspectives will foster broader discussion and eventual acceptance of principled, pre-specified, data-adaptive covariate adjustment in randomized trials.

stat.ME

Machine learning to optimize precision in the analysis of randomized trials: A journey in pre-specified, yet data-adaptive learning

Covariate adjustment is an approach to improve the precision of trial analyses by adjusting for baseline variables that are prognostic of the primary endpoint. Motivated by the SEARCH Universal HIV Test-and-Treat Trial (2013-2017), we tell our story of developing, evaluating, and implementing a machine learning-based approach for covariate adjustment. We provide the rationale for as well as the practical concerns with such an approach for estimating marginal effects. Using schematics, we illustrate our procedure: targeted machine learning estimation (TMLE) with Adaptive Pre-specification. Briefly, sample-splitting is used to data-adaptively select the combination of estimators of the outcome regression (i.e., the conditional expectation of the outcome given the trial arm and covariates) and known propensity score (i.e., the conditional probability of being randomized to the intervention given the covariates) that minimizes the cross-validated variance estimate and, thereby, maximizes empirical efficiency. We discuss our approach for evaluating finite sample performance with parametric and plasmode simulations, pre-specifying the Statistical Analysis Plan, and unblinding in real-time on video conference with our colleagues from around the world. We present the results from applying our approach in the primary, pre-specified analysis of 8 recently published trials (2022-2024). We conclude with practical recommendations and an invitation to implement our approach in the primary analysis of your next trial.

stat.ME

A causal framework for evaluating the total effect of strategies aiming to expand screening and to improve outcomes

For many health conditions, there are highly efficacious treatment and prevention products. Maximizing their impact requires strategies that improve the reach of health screening in order to establish who could benefit. For example, HIV prevention strategies aim to expand risk screening and to improve uptake of pre-exposure prophylaxis (PrEP) among those experiencing risk. Often, these strategies induce changes at the group-level (e.g., health clinics or communities) and are evaluated through cluster randomized trials. This scenario creates a complex, multilevel-mediation-missing data problem for the following reasons. First, the strategy is delivered at the cluster-level, while health screening and outcomes are at the individual-level. Second, the strategy improves health outcomes directly and indirectly through improved health screening. Third, everyone has an underlying status, which is only observed among those screened. To formally define the total effect in such settings, we use Counterfactual Strata Effects: causal estimands where the outcome is only relevant for a group whose membership is subject to missingness and/ or impacted by the exposure of interest. To identify and estimate the corresponding statistical estimand, we propose a novel extension of Two-Stage targeted minimum loss-based estimation (TMLE). Simulations demonstrate the practical performance of our approach as well as the limitations of existing approaches.

stat.ME

Causal Inference with Missing Exposures and Missing Outcomes

Missing data are ubiquitous in public health research. When estimating causal effects, there are well-established methods to address bias to due missing outcomes. Commonly, causal estimands are defined under hypothetical interventions to "set" the exposure and to prevent missingness. We demonstrate how this framework can be extended to missing exposures. We further extend this framework to incorporate missingness on the baseline outcome, which induces missingness on the population of interest (e.g., persons at-risk). To do so, we highlight Counterfactual Strata Effects, a general class of causal estimands where the focus population is subject to missingness and/or impacted by the exposure. They are termed such because the estimand involves conditioning on a counterfactual variable.For each setting, we present the causal model, relevant counterfactuals, causal estimand, and identification result. We demonstrate with a real-data example to investigate the effect of alcohol consumption on the risk of incident tuberculosis (TB) infection in rural Uganda. We highlight the use of TMLE with Super Learner for estimation and inference and discuss the practical consequences of our approach.

stat.ME

Large Language Models as Co-Pilots for Causal Inference in Medical Studies

The validity of medical studies based on real-world clinical data, such as observational studies, depends on critical assumptions necessary for drawing causal conclusions about medical interventions. Many published studies are flawed because they violate these assumptions and entail biases such as residual confounding, selection bias, and misalignment between treatment and measurement times. Although researchers are aware of these pitfalls, they continue to occur because anticipating and addressing them in the context of a specific study can be challenging without a large, often unwieldy, interdisciplinary team with extensive expertise. To address this expertise gap, we explore the use of large language models (LLMs) as co-pilot tools to assist researchers in identifying study design flaws that undermine the validity of causal inferences. We propose a conceptual framework for LLMs as causal co-pilots that encode domain knowledge across various fields, engaging with researchers in natural language interactions to provide contextualized assistance in study design. We provide illustrative examples of how LLMs can function as causal co-pilots, propose a structured framework for their grounding in existing causal inference frameworks, and highlight the unique challenges and opportunities in adapting LLMs for reliable use in epidemiological research.

cs.AI

The Causal Roadmap and Simulations to Improve the Rigor and Reproducibility of Real-Data Applications

The Causal Roadmap outlines a systematic approach to asking and answering questions of cause-and-effect: define the quantity of interest, evaluate needed assumptions, conduct statistical estimation, and carefully interpret results. To protect research integrity, it is essential that the algorithm for statistical estimation and inference be pre-specified prior to conducting any effectiveness analyses. However, it is often unclear which algorithm will perform optimally for the real-data application. Instead, there is a temptation to simply implement one's favorite algorithm -- recycling prior code or relying on the default settings of a computing package. Here, we call for the use of simulations that realistically reflect the application, including key characteristics such as strong confounding and dependent or missing outcomes, to objectively compare candidate estimators and facilitate full specification of the Statistical Analysis Plan. Such simulations are informed by the Causal Roadmap and conducted after data collection but prior to effect estimation. We illustrate with two worked examples. First, in an observational longitudinal study, outcome-blind simulations are used to inform nuisance parameter estimation and variance estimation for longitudinal targeted minimum loss-based estimation (TMLE). Second, in a cluster randomized trial with missing outcomes, treatment-blind simulations are used to examine Type-I error control in Two-Stage TMLE. In both examples, realistic simulations empower us to pre-specify an estimation approach that is expected to have strong finite sample performance and also yield quality-controlled computing code for the actual analysis. Together, this process helps to improve the rigor and reproducibility of our research.

stat.ME

When exposure affects subgroup membership: Framing relevant causal questions in perinatal epidemiology and beyond

Perinatal epidemiology often aims to evaluate exposures on infant outcomes. When the exposure affects the composition of people who give birth to live infants (e.g., by affecting fertility, behavior, or birth outcomes), this "live birth process" mediates the exposure effect on infant outcomes. Causal estimands previously proposed for this setting include the total exposure effect on composite birth and infant outcomes, controlled direct effects (e.g., enforcing birth), and principal stratum direct effects. Using perinatal HIV transmission in the SEARCH Study as a motivating example, we present two alternative causal estimands: 1) conditional total effects; and 2) conditional stochastic direct effects, formulated under a hypothetical intervention to draw mediator values from some distribution (possibly conditional on covariates). The proposed conditional total effect includes impacts of an intervention that operate by changing the types of people who have a live birth and the timing of births. The proposed conditional stochastic direct effects isolate the effect of an exposure on infant outcomes excluding any impacts through this live birth process. In SEARCH, this approach quantifies the impact of a universal testing and treatment intervention on infant HIV-free survival absent any effect of the intervention on the live birth process, within a clearly defined target population of women of reproductive age with HIV at study baseline. Our approach has implications for the evaluation of intervention effects in perinatal epidemiology broadly, and whenever causal effects within a subgroup are of interest and exposure affects membership in the subgroup.

stat.ME

Blurring cluster randomized trials and observational studies using Two-Stage TMLE to address sub-sampling, missingness, and minimal independent units

Cluster randomized trials (CRTs) often enroll large numbers of participants, but due to logistical and fiscal challenges, only a subset of participants may be selected for measurement of certain outcomes, and those sampled may, purposely or not, be unrepresentative of all participants. Missing data also present a challenge: if sampled individuals with measured outcomes are dissimilar from those with missing outcomes, unadjusted estimates of arm-specific outcomes and the intervention effect may be biased. Further, CRTs often enroll and randomize few clusters by necessity, limiting statistical power and raising concerns about finite sample performance. Motivated by a sub-study of the SEARCH community randomized trial on the incidence of TB infection, we demonstrate interlocking methods to handle these challenges. First, we extend Two-Stage targeted minimum loss-based estimation (TMLE) to account for three sources of missingness: (1) sampling for the sub-study; (2) measurement of baseline status among those sampled, and (3) measurement of final status among those in the incidence cohort (i.e., persons known to be at risk at baseline). Second, we critically evaluate the assumptions under which sub-units of the cluster can be considered the conditionally independent unit, improving precision and statistical power but also causing the CRT to behave more like an observational study. Our application to the SEARCH highlights the impact of different assumptions on measurement and dependence as well as the real-life gains of our approach for bias reduction and efficiency improvement.

stat.ME

Defining and Estimating Effects in Cluster Randomized Trials: A Methods Comparison

Across research disciplines, cluster randomized trials (CRTs) are commonly implemented to evaluate interventions delivered to groups of participants, such as communities and clinics. Despite advances in the design and analysis of CRTs, several challenges remain. First, there are many possible ways to specify the causal effect of interest (e.g., at the individual-level or at the cluster-level). Second, the theoretical and practical performance of common methods for CRT analysis remain poorly understood. Here, we present a general framework to formally define an array of causal effects in terms of summary measures of counterfactual outcomes. Next, we provide a comprehensive overview of CRT estimators, including the t-test, generalized estimating equations (GEE), augmented-GEE, and targeted maximum likelihood estimation (TMLE). Using finite sample simulations, we illustrate the practical performance of these estimators for different causal effects and when, as commonly occurs, there are limited numbers of clusters of different sizes. Finally, our application to data from the Preterm Birth Initiative (PTBi) study demonstrates the real-world impact of varying cluster sizes and targeting effects at the cluster-level or at the individual-level. Specifically, the relative effect of the PTBI intervention was 0.81 at the cluster-level, corresponding to a 19% reduction in outcome incidence, and was 0.66 at the individual-level, corresponding to a 34% reduction in outcome risk. Given its flexibility to estimate a variety of user-specified effects and ability to adaptively adjust for covariates for precision gains while maintaining Type-I error control, we conclude TMLE is a promising tool for CRT analysis.

stat.ME

Statistical Analysis Plan for Primary and Selected Secondary Health Endpoints of the SEARCH-Youth Study

This document provides the statistical analytic plan (SAP) for evaluating health outcomes in the SEARCH-Youth study, a cluster randomized trial designed to evaluate the effect of a combination intervention on HIV viral suppression among adolescents and young adults with HIV in rural Uganda and Kenya (Clinicaltrials.gov: NCT03848728). The SAP was locked prior to unblinding and effect estimation. This SAP was embargoed until November 04, 2022 when it was submitted to arXiv.

stat.AP

Adaptive Selection of the Optimal Strategy to Improve Precision and Power in Randomized Trials

Benkeser et al. demonstrate how adjustment for baseline covariates in randomized trials can meaningfully improve precision for a variety of outcome types. Their findings build on a long history, starting in 1932 with R.A. Fisher and including more recent endorsements by the U.S. Food and Drug Administration and the European Medicines Agency. Here, we address an important practical consideration: *how* to select the adjustment approach -- which variables and in which form -- to maximize precision, while maintaining Type-I error control. Balzer et al. previously proposed *Adaptive Prespecification* within TMLE to flexibly and automatically select, from a prespecified set, the approach that maximizes empirical efficiency in small trials (N$<$40). To avoid overfitting with few randomized units, selection was previously limited to working generalized linear models, adjusting for a single covariate. Now, we tailor Adaptive Prespecification to trials with many randomized units. Using $V$-fold cross-validation and the estimated influence curve-squared as the loss function, we select from an expanded set of candidates, including modern machine learning methods adjusting for multiple covariates. As assessed in simulations exploring a variety of data generating processes, our approach maintains Type-I error control (under the null) and offers substantial gains in precision -- equivalent to 20-43\% reductions in sample size for the same statistical power. When applied to real data from ACTG Study 175, we also see meaningful efficiency improvements overall and within subgroups.

stat.ME

Evaluating shifts in mobility and COVID-19 case rates in U.S. counties: A demonstration of modified treatment policies for causal inference with continuous exposures

Previous research has shown mixed evidence on the associations between mobility data and COVID-19 case rates, analysis of which is complicated by differences between places on factors influencing both behavior and health outcomes. We aimed to evaluate the county-level impact of shifting the distribution of mobility on the growth in COVID-19 case rates from June 1 - November 14, 2020. We utilized a modified treatment policy (MTP) approach, which considers the impact of shifting an exposure away from its observed value. The MTP approach facilitates studying the effects of continuous exposures while minimizing parametric modeling assumptions. Ten mobility indices were selected to capture several aspects of behavior expected to influence and be influenced by COVID-19 case rates. The outcome was defined as the number of new cases per 100,000 residents two weeks ahead of each mobility measure. Primary analyses used targeted minimum loss-based estimation (TMLE) with a Super Learner ensemble of machine learning algorithms, considering over 20 potential confounders capturing counties' recent case rates as well as social, economic, health, and demographic variables. For comparison, we also implemented unadjusted analyses. For most weeks considered, unadjusted analyses suggested strong associations between mobility indices and subsequent growth in case rates. However, after confounder adjustment, none of the indices showed consistent associations after hypothetical shifts to reduce mobility. While identifiability concerns limit our ability to make causal claims in this analysis, MTPs are a powerful and underutilized tool for studying the effects of continuous exposures.

stat.AP

Statistical Analysis Plan for Health Outcomes in Phase 1 of the SEARCH-IPT Study

This document provides the statistical analytic plan (SAP) for evaluating health outcomes in Phase 1 of the SEARCH-IPT Study, a cluster randomized trial to evaluate whether a multicomponent intervention increases uptake of isoniazid (INH) preventive therapy (IPT) and reduces the incidence of tuberculosis (TB) in Uganda (Clinicaltrials.gov: NCT03315962). The SAP was locked prior to unblinding and effect estimation. This SAP was embargoed until November 19, 2021 when it was submitted to arXiv.

stat.AP

Two-Stage TMLE to Reduce Bias and Improve Efficiency in Cluster Randomized Trials

Cluster randomized trials (CRTs) randomly assign an intervention to groups of individuals (e.g., clinics or communities) and measure outcomes on individuals in those groups. While offering many advantages, this experimental design introduces challenges that are only partially addressed by existing analytic approaches. First, outcomes are often missing for some individuals within clusters. Failing to appropriately adjust for differential outcome measurement can result in biased estimates and inference. Second, CRTs often randomize limited numbers of clusters, resulting in chance imbalances on baseline outcome predictors between arms. Failing to adaptively adjust for these imbalances and other predictive covariates can result in efficiency losses. To address these methodological gaps, we propose and evaluate a novel two-stage targeted minimum loss-based estimator (TMLE) to adjust for baseline covariates in a manner that optimizes precision, after controlling for baseline and post-baseline causes of missing outcomes. Finite sample simulations illustrate that our approach can nearly eliminate bias due to differential outcome measurement, while existing CRT estimators yield misleading results and inferences. Application to real data from the SEARCH community randomized trial demonstrates the gains in efficiency afforded through adaptive adjustment for baseline covariates, after controlling for missingness on individual-level outcomes.

stat.ME

Evaluating the Impact of State-Level Public Masking Mandates on New COVID-19 Cases and Deaths in the United States: A Demonstration of the Causal Roadmap

At a national-level, we sought to investigate the effect of public masking mandates on COVID-19 in Fall 2020. Specifically, we aimed to evaluate how the relative growth of COVID-19 cases and deaths would have differed if all states had issued a mandate to mask in public by September 1, 2020 versus if all states had delayed issuing such a mandate. To do so, we applied the Causal Roadmap, a formal framework for causal and statistical inference. The outcome was defined as the state-specific relative increase in cumulative cases and in cumulative deaths {21, 30, 45, 60}-days after September 1. Despite the natural experiment in state-level masking policies, the causal effect of interest was not identifiable. Nonetheless, we specified the target statistical parameter as the adjusted rate ratio (aRR): the expected outcome with early implementation divided by the expected outcome with delayed implementation, after adjusting for state-level confounders. To minimize strong estimation assumptions, primary analyses used targeted maximum likelihood estimation (TMLE) with Super Learner. After 60-days and at a national-level, early implementation was associated 9% reduction in new COVID-19 cases (aRR: 0.91; 95%CI: 0.88-0.95) and a 16% reduction in new COVID-19 deaths (aRR: 0.84; 95%CI: 0.76-0.93). Although lack of identifiability prohibited causal interpretations, application of the Causal Roadmap facilitated estimation and inference of statistical associations, providing timely answers to pressing questions in the COVID-19 response.

stat.AP

The covariate-adjusted residual estimator and its use in both randomized trials and observational settings

We often seek to estimate the causal effect of an exposure on a particular outcome in both randomized and observational settings. One such estimation method is the covariate-adjusted residuals estimator, which was designed for individually or cluster randomized trials. In this manuscript, we study the properties of this estimator and develop a new estimator that utilizes both covariate adjustment and inverse probability weighting We support our theoretical results with a simulation study and an application in an infectious disease setting. The covariate-adjusted residuals estimator is an efficient and unbiased estimator of the average treatment effect in randomized trials; however, it is not guaranteed to be unbiased in observational studies. Our novel estimator, the covariate-adjusted residuals estimator with inverse probability weighting, is unbiased in randomized and observational settings, under a reasonable set of assumptions. Furthermore, when these assumptions hold, it provides efficiency gains over inverse probability weighting in observational studies. The covariate-adjusted residuals estimator is valid for use in randomized trials, but should not be used in observational studies. The covariate-adjusted residuals estimator with inverse probability weighting provides an efficient alternative for use in randomized and observational settings.

stat.ME

A Primer on Causality in Data Science

Many questions in Data Science are fundamentally causal in that our objective is to learn the effect of some exposure, randomized or not, on an outcome interest. Even studies that are seemingly non-causal, such as those with the goal of prediction or prevalence estimation, have causal elements, including differential censoring or measurement. As a result, we, as Data Scientists, need to consider the underlying causal mechanisms that gave rise to the data, rather than simply the pattern or association observed in those data. In this work, we review the 'Causal Roadmap' of Petersen and van der Laan (2014) to provide an introduction to some key concepts in causal inference. Similar to other causal frameworks, the steps of the Roadmap include clearly stating the scientific question, defining of the causal model, translating the scientific question into a causal parameter, assessing the assumptions needed to express the causal parameter as a statistical estimand, implementation of statistical estimators including parametric and semi-parametric methods, and interpretation of our findings. We believe that using such a framework in Data Science will help to ensure that our statistical analyses are guided by the scientific question driving our research, while avoiding over-interpreting our results. We focus on the effect of an exposure occurring at a single time point and highlight the use of targeted maximum likelihood estimation (TMLE) with Super Learner.

stat.AP